Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Gritstone bio Inc. (GRTS : NSDQ)

• Company Description    Gritstone Oncology is developing tumor-specific cancer immunotherapies to fight multiple cancer types. The company has built its tumor-specific immunotherapy approach on two key pillars - first, a proprietary machine learning-based platform, Gritstone EDGE(TM), which provides a powerful ability to predict from a routine tumor biopsy the tumor-specific neoantigens, or TSNA, that are presented on a patient?s tumor cells; and second, the ability to develop and manufacture potent immunotherapies utilizing patients? TSNA to drive the patient?s immune system to attack and destroy tumors. Number of Employees: 193

• Price / Volume Information    Yesterday's Closing Price: $1.95 Daily Weekly Monthly 20 Day Moving Average: 1,188,551 shares Shares Outstanding: 72.81 (millions) Market Capitalization: $141.99 (millions) Beta: 0.67 52 Week High: $14.42 52 Week Low: $1.82 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -38.49% -30.71% 12 Week -60.76% -56.86% Year To Date -84.84% -81.47%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 5959 HORTON STREET SUITE 300 - EMERYVILLE,CA 94608 USA ph: 510-871-6100 fax: - ir@gritstone.com http://www.gritstoneoncology.com

• General Corporate Information    Officers Andrew Allen - President; Chief Executive Officer and Director Elaine Jones - Chairperson Vassiliki Economides - Chief Financial Officer James Cho - Chief Accounting Officer Clare Fisher - Director Peer Information Gritstone bio Inc. (CORR.) Gritstone bio Inc. (RSPI) Gritstone bio Inc. (CGXP) Gritstone bio Inc. (BGEN) Gritstone bio Inc. (GTBP) Gritstone bio Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 39868T105 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/04/22 Share - Related Items Shares Outstanding: 72.81 Most Recent Split Date: (:1) Beta: 0.67 Market Capitalization: $141.99 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-0.40 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.51 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 2.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/04/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 0.75 Price/Cash Flow: - Price / Sales: 9.04 EPS Growth vs. Year Ago Period: -440.00% vs. Previous Quarter: 5.56% Sales Growth vs. Year Ago Period: -81.88% vs. Previous Quarter: 134.69% ROE 03/31/22 - -56.52 12/31/21 - -37.44 09/30/21 - -38.51 ROA 03/31/22 - -44.02 12/31/21 - -29.43 09/30/21 - -30.07 Current Ratio 03/31/22 - 5.65 12/31/21 - 5.52 09/30/21 - 6.01 Quick Ratio 03/31/22 - - 12/31/21 - 5.52 09/30/21 - 6.01 Operating Margin 03/31/22 - -712.33 12/31/21 - -155.73 09/30/21 - -155.88 Net Margin 03/31/22 - -712.33 12/31/21 - -155.73 09/30/21 - -155.88 Pre-Tax Margin 03/31/22 - -712.33 12/31/21 - -155.73 09/30/21 - -155.88 Book Value 03/31/22 - 2.60 12/31/21 - 3.18 09/30/21 - 3.06 Inventory Turnover 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Equity 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00 Debt-to-Capital 03/31/22 - 0.00 12/31/21 - 0.00 09/30/21 - 0.00

Powered by Zacks Investment Research ©